Research Grade Denosumab (DHA30301)

Tags: Denosumab ( 地舒单抗 ) supplier,Denosumab ( 地舒单抗 ) purchase,Denosumab ( 地舒单抗 ) manufacturer,Denosumab ( 地舒单抗 ) distributor,Denosumab ( 地舒单抗 ) cost,Denosumab ( 地舒单抗 ) buy,Denosumab ( 地舒单抗 ) for sale

Catalog No.

DHA30301

Host species

Homo sapiens

Species reactivity

Human

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Concentration

1 mg/ml

Purity

>95%

Clonality

Monoclonal

Isotype

IgG2-kappa

Applications

Research Grade Denosumab Biosimilar

Target

ODF,TNF-related activation-induced cytokine,Osteoclast differentiation factor,TNFSF11,TRANCE,Osteoprotegerin ligand,RANKL,Tumor necrosis factor ligand superfamily member 11,Receptor activator of nuclear factor kappa-B ligand,CD254,OPGL

Purification

Protein A or G purified from cell culture supernatant.

Endotoxin level

Please contact with the lab for this information.

Expression system

Mammalian cells

Accession

O14788

Stability ａnd Storage

Use a manual defrost freezer ａnd avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Alternative Names

AMG162, CAS: 615258-40⁻⁷

Note

For research use only. Not suitable for clinical or therapeutic use.

Aiming to develop the most reliable bioreagents, AntibodySystem SAS was founded in 2019 in France by a team of professionals from industrial companies ａnd research institutes. The collective scientific ａnd technical experiences in our team have brought breaking throughs in multiple product developments, including recombinant antibodies, recombinant proteins, biosimilar, RUO ELISA kits ａnd other related products. By working with talented researchers ａnd technicians, AntibodySystem continues to upgrade product qualities ａnd lower the overall cost, offering accountable ａnd affordable solutions for biolabs all over the world. Since its establishment, AntibodySystem has built long term ａnd stable collaborations with academia, pharmaceutical industry, biotech companies ａnd research hospitals, supporting their R&D by AntibodySystem＇s bioreagents with excellent data accuracy ａnd reproducibility.

AntibodySystem由具有30多年蛋白抗体开发经验的 创立于法国,注于生命科学和生物制药域研究,总部位于法国斯特拉斯堡市。AntibodySystem自主开发了高效、高产的真核重组表达系统,利用该系统生产了高质量的重组蛋白、抗体产品。目产品包括药物靶点蛋白以及对照抗体药物、Invivo功能性抗体、SAA系列流式抗体、PEG抗体、磷酸化抗体、抗小分子抗体、ADA抗体、PK&ADA ELISA试剂盒。